Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001140361-25-046923
Filing Date
2025-12-31
Accepted
2025-12-30 19:58:22
Documents
9
Effectiveness Date
2025-12-31

Document Format Files

Seq Description Document Type Size
1 S-8 POS ef20061614_s8pos.htm S-8 POS 66275
2 EXHIBIT 3.1 ef20061614_ex3-1.htm EX-3.1 33622
3 EXHIBIT 3.2 ef20061614_ex3-2.htm EX-3.2 237200
4 EXHIBIT 5.1 ef20061614_ex5-1.htm EX-5.1 15668
5 EXHIBIT 23.2 ef20061616_ex23-2.htm EX-23.2 2456
6 EXHIBIT 23.3 ef20061614_ex23-3.htm EX-23.3 1895
7 EXHIBIT 99.1 ef20061614_ex99-1.htm EX-99.1 100409
8 image00001.jpg GRAPHIC 3615
9 image00002.jpg GRAPHIC 2083
  Complete submission text file 0001140361-25-046923.txt   467733
Mailing Address PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183
Business Address PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183 49 89 2153 9035
Atai Beckley N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-257482 | Film No.: 251615513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address PROFESSOR J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183 AT
Business Address PROFESSOR J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183 AT 31207932536
atai Life Sciences Luxembourg S.A. (Filer) CIK: 0002081043 (see all company filings)

EIN.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-257482-01 | Film No.: 251615514
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)